NNM Securities

ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC

BSE25780.00-481.45 (-1.83 %)

PREV CLOSE ( ) 26261.45

OPEN PRICE ( ) 26263.00

BID PRICE (QTY) 25716.95 (4)

OFFER PRICE (QTY) 25757.55 (1)

VOLUME 566

TODAY'S LOW / HIGH ( )25666.65 26263.00

52 WK LOW / HIGH ( )20594.25 29628.15

NSE25695.00-621 (-2.36 %)

PREV CLOSE( ) 26316.00

OPEN PRICE ( ) 26250.00

BID PRICE (QTY) 25694.45 (1)

OFFER PRICE (QTY) 25698.90 (6)

VOLUME 22031

TODAY'S LOW / HIGH( ) 25666.00 26250.00

52 WK LOW / HIGH ( )20605.05 29638.95

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 22-08 1944

Management Info

Munir Shaikh - Chairman - Managing Director

Registered Office

Address Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone 022-50461000 / 2000 / 67978888

Email webmasterindia@abbott.com / investorrelations.india@abbott.com

Website www.abbott.co.in

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, MCX

NEWS

12Apr Abbott India informs about appointment
In compliance with Regulation 30 of the Securities and Exchange Board of..

27Mar Abbott India informs about newspaper a
Pursuant to Regulation 47 of the Securities and Exchange Board of India..

19Mar Abbott India informs about resignation
With reference to its earlier communication dated December 19, 2023, whe..

15Mar Abbott India informs about change in s
Pursuant to Regulation 30 read with Clause 7 of Para A of Part A of Sche..

13Mar Abbott India informs about change in d
Pursuant to Regulation 30 read with Clause 7 of Para A of Part A of Sche..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	3109.8	9494.1
Gross Profit	4221.6	12738.2
Operating Profit	4433	13597.8
Net Sales	14371.4	53487.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE) 4765.20 (1.38%)	M.Cap (Rs. in Cr)7906.62
Fredun Pharma (BSE) 829.00 (8.34%)	M.Cap (Rs. in Cr)387.18
Mankind Pharma (BSE) 2392.25 (2.33%)	M.Cap (Rs. in Cr)96007.03
Ajanta Pharma (BSE) 2142.05 (2.47%)	M.Cap (Rs. in Cr)27069.35
Torrent Pharma (BSE) 2634.95 (1.71%)	M.Cap (Rs. in Cr)89263.29

Shareholding Pattern

	PROMOTERS	74.99%
	NON-INSTITUTION	15.92%
	MUTUAL FUNDS/UTI	7.57%
	FI/BANKS/INSURANCE	1.23%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
SBI Magnum Global F...	5.75
LIC MF Healthcare F...	4.51
NJ ELSS Tax Saver S...	3.76
SBI Healthcare Opp ...	3.72
Nippon India Pharma...	3.29
Samco ELSS Tax Save...	3.10
Aditya Birla SL Pha...	3.10

ATTENTION INVESTORSKYCIPO

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :

Assamese	Bengali	Gujrati	Hindi	Kanada
Kashmiri	Konkani	Malyalam	Marathi	Oriya
Punjabi	Sindhi	Tamil	Telegu	Urdu

REGISTRATION NOS.

Filing compliant on SCORES – Easy & quick

Register on SCORES portal
Mandatory details for filing complaints on SCORES:
- Name
- PAN
- Address
- Mobile Number
- E-mail ID
Benefits:
- i.) Effective communication
- ii.) Speedy redressal of the grievances

SMART ODR Portal

INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

NNM Securities

Smart Quotes

ABBOTT INDIA LTD.

Filing compliant on SCORES – Easy & quick